JP5377815B2 - Cosmetic composition for enhancing skin elasticity - Google Patents

Cosmetic composition for enhancing skin elasticity Download PDF

Info

Publication number
JP5377815B2
JP5377815B2 JP2005143034A JP2005143034A JP5377815B2 JP 5377815 B2 JP5377815 B2 JP 5377815B2 JP 2005143034 A JP2005143034 A JP 2005143034A JP 2005143034 A JP2005143034 A JP 2005143034A JP 5377815 B2 JP5377815 B2 JP 5377815B2
Authority
JP
Japan
Prior art keywords
extract
skin elasticity
elastin
cosmetic composition
ginkgo biloba
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2005143034A
Other languages
Japanese (ja)
Other versions
JP2005330281A (en
Inventor
ヨウン ジューン キム
サン イル リー
ハン コン キム
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amorepacific Corp
Original Assignee
Amorepacific Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amorepacific Corp filed Critical Amorepacific Corp
Publication of JP2005330281A publication Critical patent/JP2005330281A/en
Application granted granted Critical
Publication of JP5377815B2 publication Critical patent/JP5377815B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A45HAND OR TRAVELLING ARTICLES
    • A45CPURSES; LUGGAGE; HAND CARRIED BAGS
    • A45C1/00Purses; Money-bags; Wallets
    • A45C1/12Savings boxes
    • AHUMAN NECESSITIES
    • A45HAND OR TRAVELLING ARTICLES
    • A45CPURSES; LUGGAGE; HAND CARRIED BAGS
    • A45C13/00Details; Accessories
    • AHUMAN NECESSITIES
    • A45HAND OR TRAVELLING ARTICLES
    • A45CPURSES; LUGGAGE; HAND CARRIED BAGS
    • A45C1/00Purses; Money-bags; Wallets
    • A45C1/10Money-bags for conductors or like people; Money-bags with rigid coin-holders
    • A45C2001/102Rigid coin-holders
    • AHUMAN NECESSITIES
    • A45HAND OR TRAVELLING ARTICLES
    • A45CPURSES; LUGGAGE; HAND CARRIED BAGS
    • A45C2200/00Details not otherwise provided for in A45C
    • A45C2200/05Means for indicating features of the content from outside

Landscapes

  • Cosmetics (AREA)

Description

本発明は、有効成分として銀杏葉抽出物(Ginkgo extract)、トウキ抽出物(Angelica acutiloba root extract)及び酵母抽出物(Yeast extract)を含有する皮膚弾力増進用化粧料組成物に関する。より詳細には、本発明は、有効成分として銀杏葉抽出物、トウキ抽出物及び酵母抽出物を含有し、各抽出物の複合相乗作用により、血色を改善し、小ジワを防止し、且つ真皮−表皮境界層を改善させることによって、これら表皮及び真皮を改善させ、皮膚弾力を向上させる皮膚弾力増進用化粧料組成物に関する。   The present invention relates to a cosmetic composition for enhancing skin elasticity, which contains Ginkgo extract, Angelica acutiloba root extract and Yeast extract as active ingredients. More specifically, the present invention contains Ginkgo biloba extract, Toki extract and yeast extract as active ingredients, improves the blood color, prevents fine wrinkles, and prevents the dermis by the combined synergistic action of each extract. -It relates to a cosmetic composition for enhancing skin elasticity, which improves the epidermis and dermis by improving the epidermal boundary layer, thereby improving skin elasticity.

皮膚弾力は、真皮層に存在するエラスチン(elastin)から構成される弾力繊維により形成される。かかる弾力繊維は、ゴムのように非常に低い弾性係数を有していて、小さな力によっても容易に変形し、その力が除去された時には、容易に原形に戻る。また、弾力繊維は、エラスチンという無定形の基質にミクロフィブリル(microfibrils)が埋めこまれた形態を有する。エラスチンは、リジン(lysine)に由来するデスモシン(desmosine)やイソデスモシン(isodesmosine)のような弾力繊維でのみ発見される、非常に独特なアミノ酸から構成された蛋白質である。このデスモシンやイソデスモシンなどは、長いペプチド鎖の中で架橋(cross-links)を形成しているが、このような構造により、エラスチンはゴムのような性質を有するようになる。   Skin elasticity is formed by elastic fibers composed of elastin present in the dermis layer. Such elastic fibers have a very low elastic modulus like rubber, and are easily deformed even by a small force, and easily return to the original shape when the force is removed. The elastic fiber has a form in which microfibrils are embedded in an amorphous substrate called elastin. Elastin is a protein composed of very unique amino acids found only in elastic fibers such as desmosine and isodesmosine derived from lysine. Such desmosine, isodesmosine, and the like form cross-links in a long peptide chain. Due to such a structure, elastin has a rubber-like property.

また、エラスチンから構成される弾力繊維は、コラーゲン(collagen)という膠原繊維と一緒に存在し、このエラスチンとコラーゲンが十分に存在する状態で皮膚弾力の維持が可能となる。   Elastic fibers composed of elastin exist together with collagen fibers called collagen, and the skin elasticity can be maintained in a state where the elastin and collagen are sufficiently present.

一方、皮膚弾力の低下は、老化や紫外線などに起因して皮膚細胞(繊維芽細胞)が弱化することに伴う、エラスチンの生成低下及び破壊により誘発される。すなわち、紫外線などにより皮膚内にエラスチン分解酵素が発現されると、この酵素は皮膚内の正常なエラスチンを分解して、皮膚弾力の低下をもたらす。また、皮膚弾力の低下は、皮膚真皮の70%以上を構成するコラーゲンという蛋白質の損傷及び生成低下によっても発生する。コラーゲンも、紫外線などにより誘発されるコラゲナーゼ(collagenase)という分解酵素により分解される。   On the other hand, a decrease in skin elasticity is induced by a decrease in production and destruction of elastin accompanying weakening of skin cells (fibroblasts) due to aging, ultraviolet rays, and the like. That is, when elastin degrading enzyme is expressed in the skin by ultraviolet rays or the like, this enzyme degrades normal elastin in the skin, resulting in a decrease in skin elasticity. In addition, the skin elasticity is reduced due to the damage and reduced production of a protein called collagen that constitutes 70% or more of the skin dermis. Collagen is also degraded by a degrading enzyme called collagenase that is induced by ultraviolet rays or the like.

一方、皮膚弾力の増大に関連する先行特許としては、レグミノサ種子(Leguminosae Seeds)から得られた蛋白質分画が弾力増大効果を示すことを記載する米国特許第5,322,839号、麦芽抽出物(malt extract)などを含む組成物がコラゲナーゼ(collagenase)を抑制するのに利用されることを記載する日本国特許第5,105,693号、コラゲナーゼまたはエラスターゼの抑制剤として、カルバミン酸ペプチド(peptidyl carbamates)、チオカルバミン酸ペプチド(peptidyl thiocarbamates)、ヒドロキサメート(hydroxamates)、セファロスポリン(cephalosporins)、スルホン酸塩(sulphonate salts)などを含有する化粧料組成物を提供する米国特許第5,614,489号などが挙げられる。   On the other hand, as a prior patent related to the increase in skin elasticity, US Pat. No. 5,322,839, which describes that a protein fraction obtained from Leguminosae Seeds shows an effect of increasing elasticity, malt extract Japanese Patent No. 5,105,693, which describes that a composition containing (malt extract) or the like is used for inhibiting collagenase, and as an inhibitor of collagenase or elastase, carbamate peptide (peptidyl) US Pat. No. 5,614, which provides cosmetic compositions containing carbamates, peptidyl thiocarbamates, hydroxamates, cephalosporins, sulphonate salts, and the like. , 489 and the like.

しかしながら、上記先行特許は、皮膚弾力の増大効果を得るために、単純にコラゲナーゼの活性を抑制させたり、エラスターゼの活性を抑制したものであって、真皮層に限定して作用するため、その機能が十分発揮されないという短所がある。   However, in order to obtain the effect of increasing skin elasticity, the above-mentioned prior patents simply suppress the activity of collagenase or suppress the activity of elastase, and function only in the dermis layer. Has the disadvantage of not being fully demonstrated.

これより、本発明者らは、皮膚弾力を最大限増大させることができる化粧料組成物について研究した結果、銀杏葉抽出物、トウキ抽出物及び酵母抽出物のような水溶性活性成分を化粧料組成物に含有させた場合、それぞれの相互作用が複合することにより皮膚弾力が増進されることを見出し、本発明を完成するに至った。   As a result of studying cosmetic compositions capable of maximizing skin elasticity, the present inventors have found that water-soluble active ingredients such as Ginkgo biloba extract, Toki extract and yeast extract are used as cosmetics. When it was contained in the composition, it was found that the skin elasticity was enhanced by the combination of the respective interactions, and the present invention was completed.

したがって、本発明の目的は、有効成分として銀杏葉抽出物、トウキ抽出物及び酵母抽出物を含有する皮膚弾力増進用化粧料組成物を提供することにある。   Accordingly, an object of the present invention is to provide a cosmetic composition for enhancing skin elasticity, which contains a ginkgo biloba extract, a toki extract and a yeast extract as active ingredients.

前記目的を達成するために、本発明の皮膚弾力増進用化粧料組成物は、有効成分として銀杏葉抽出物、トウキ抽出物及び酵母抽出物を、組成物の総重量に対して各々0.01〜10.0重量%の量で含有することを特徴とする。   In order to achieve the above-mentioned object, the cosmetic composition for enhancing skin elasticity of the present invention comprises, as active ingredients, a ginkgo biloba extract, a Toki extract and a yeast extract, each 0.01% relative to the total weight of the composition. It is contained in an amount of ˜10.0% by weight.

本発明の皮膚弾力増進用化粧料組成物は、エラスチンの分解を防ぐ効果のある銀杏葉抽出物、コラーゲンの分解を防ぐ効果のあるトウキ抽出物、及びコラーゲンの合成を増大させると共に、インテグリンの合成を増大させる効果のある酵母抽出物を含有することによって、それぞれの複合相乗作用により、皮膚弾力効果に優れる化粧料組成物を提供することができる。   The cosmetic composition for enhancing skin elasticity of the present invention is a ginkgo biloba extract that has an effect of preventing the degradation of elastin, an extract of Toki that has an effect of preventing the degradation of collagen, and the synthesis of integrin. By containing a yeast extract that has an effect of increasing the amount of the composition, a cosmetic composition having an excellent skin elasticity effect can be provided by the combined synergistic action.

以下、本発明をより詳細に説明する。   Hereinafter, the present invention will be described in more detail.

本発明に使われる銀杏葉抽出物は、イチョウ科の落葉喬木(GINKGO BILOBA L.)の葉を、親水性溶媒である1、3−ブチレングリコール及び水を用いて抽出した銀杏葉抽出物である。   The ginkgo biloba extract used in the present invention is a ginkgo biloba extract obtained by extracting leaves of GINKGO BILOBA L. using 1,3-butylene glycol, which is a hydrophilic solvent, and water. .

一般に、銀杏葉抽出物は、葉のフラボノイドと芳香族オキシカルボン酸とからなる総合成分であって、細い動脈の血流障害を改善し、血栓を予防及び治療する作用を有する。また、葉は、手足がしびれ、細い動脈の血流障害をきたす疾病を治療するのに用いられ、膿菌、ジフテリア菌、葡萄球菌、チフス菌、赤痢菌などを抑制する抗菌作用と共に、抗アレルギー効果などを有する。   In general, Ginkgo biloba leaf extract is a total component composed of leaf flavonoids and aromatic oxycarboxylic acid, and has an effect of improving blood flow disturbance in fine arteries and preventing and treating thrombus. In addition, the leaves are used to treat diseases that cause numbness of limbs and blood flow in fine arteries, and have anti-allergic properties as well as antibacterial activity that suppresses Pseudomonas, Diphtheria, Ryukyu, Typhi, Shigella Has effects and the like.

本発明に使われるトウキ抽出物(ANGELICA ACUTILOBA)は、双子葉植物離弁花亜綱傘形花目セリ科の多年生草であって、その根を、親水性溶媒である1、3−ブチレングリコール及び水を用いて抽出した抽出物である。   The citrus extract (ANGELICA ACUTILOBA) used in the present invention is a perennial grass of the dicotyledonous leaflet flower subfamily Umbrella type Apiaceae, and its root is 1,3-butylene glycol, which is a hydrophilic solvent. And an extract extracted with water.

一般に、トウキ抽出物は、補血・養血に重要な薬材であって、漢方では広く知られており、顔色が青白い場合に効果があり、目眩や動悸などの症状をも改善する。特に、心血不足と損傷などを治療し、於血を取り除き、新しい血を生成させる効能に優れる。また、大腸菌、チフス菌などに対して抑制作用をし、ビタミンE欠乏症に拮抗する作用をし、潤腸して通便し、肝臓を保護して肝グリコーゲン(glycogen)の減少を防ぐ。   In general, Toki extract is an important drug material for blood replacement and blood feeding, and is widely known in Chinese medicine. It is effective when the complexion is pale, and improves symptoms such as dizziness and palpitation. In particular, it is effective in treating lack of heart blood and injury, removing blood, and generating new blood. In addition, it acts to suppress E. coli, Salmonella typhi, etc., antagonizes vitamin E deficiency, intestines and stool, protects the liver and prevents the reduction of glycogen.

本発明に使われる酵母抽出物は、酵母を微生物発酵により生成抽出して得たものである。一般に、酵母抽出物は、コラーゲンIV、コラーゲンVII及びインテグリン(Integrin)の合成を促進させる機能がある。   The yeast extract used in the present invention is obtained by producing and extracting yeast by microbial fermentation. In general, yeast extract has a function of promoting the synthesis of collagen IV, collagen VII and integrin.

本発明の皮膚弾力増進用化粧料組成物は、有効成分として銀杏葉抽出物、トウキ抽出物及び酵母抽出物を組成物の総重量に対して各々0.01〜10.0重量%の量で含有する。   In the cosmetic composition for enhancing skin elasticity of the present invention, Ginkgo biloba extract, Toki extract and yeast extract are used as active ingredients in amounts of 0.01 to 10.0% by weight, respectively, based on the total weight of the composition. contains.

本発明の皮膚弾力増進用化粧料組成物は、その剤型は特に限定されず、具体的には、例えば、柔軟化粧水、栄養化粧水、栄養クリーム、マッサージクリーム、エッセンスなどの剤型として製造することができる。   The dosage form of the cosmetic composition for enhancing skin elasticity of the present invention is not particularly limited. Specifically, for example, it is produced as a dosage form such as soft lotion, nutritional lotion, nutritional cream, massage cream, essence and the like. can do.

以下、試験例及び実施例により本発明を詳細に説明するが、本発明がこれらの例だけに限定されるものではない。   EXAMPLES Hereinafter, although this invention is demonstrated in detail by a test example and an Example, this invention is not limited only to these examples.

[試験例1]銀杏葉抽出物のエラスチン生成促進効果
ヒトから直接採取するか、市販のヒトの繊維芽細胞を銀杏葉抽出物で処理して、エラスターゼ(elastase)活性の抑制効果を測定した。具体的な実験方法は、下記の通りである。
[Test Example 1] Elastin production promoting effect of Ginkgo biloba extract It was collected directly from humans, or commercially available human fibroblasts were treated with Ginkgo biloba extract, and the inhibitory effect on elastase activity was measured. The specific experimental method is as follows.

実験に使用する銀杏葉抽出物は、商品名が銀杏葉抽出物(GINKO EXTRACT, BIOLAND Co.の製品)である銀杏葉抽出物を利用した。   As the Ginkgo biloba extract used in the experiment, the Ginkgo biloba extract whose trade name is Ginko Extract (product of GINKO EXTRACT, BIOLAND Co.) was used.

まず、ヒトの繊維芽細胞を培養用フラスコに入れ、約70〜80%程度成長するまで培養した後、銀杏葉抽出物を1日間処理し、細胞培養液を採取して、市販のエラスチン測定器具を用いてエラスチンの生成度を測定した(Biochemical Medicine 11:350-357, 1974“The synthesis and analytical use of a highly sensitive and covenient substrate of elastase”及びJ. Invest Dermatol 86:63-68, 1986 “Elastase and neutral cathepsin production by human fibroblasts effect of culture conditions on synthesis and secretion”参照)。すなわち、エラスターゼの基質であるSuc−(Ala)3NAを用いて、NAの分解につれて生じる色の変化を、吸光度を用いて測定することにより、エラスターゼの活性度を測定した。この際、銀杏葉抽出物で処理しない群を対照群として使用した。実験結果を下記表1に示す。

Figure 0005377815
First, human fibroblasts are placed in a culture flask and cultured until they grow to about 70 to 80%, and then the ginkgo biloba extract is treated for 1 day, and the cell culture solution is collected to obtain a commercially available elastin measuring instrument. Was used to measure the production of elastin (Biochemical Medicine 11: 350-357, 1974 “The synthesis and analytical use of a highly sensitive and covenient substrate of elastase” and J. Invest Dermatol 86: 63-68, 1986 “Elastase and neutral cathepsin production by human fibroblasts effect of culture conditions on synthesis and secretion ”). That is, the activity of elastase was measured by measuring the color change caused by NA degradation using Suc- (Ala) 3NA, which is a substrate for elastase, using absorbance. At this time, a group not treated with Ginkgo biloba extract was used as a control group. The experimental results are shown in Table 1 below.
Figure 0005377815

[試験例2]トウキ抽出物のコラーゲン生成促進効果
ヒトから直接採取するか、市販されているヒトの繊維芽細胞をトウキ抽出物で処理して、コラゲナーゼ活性の抑制効果を測定した。具体的な実験方法は、下記の通りである。
[Test Example 2] Collagen production promoting effect of Toki extract A human fibroblast was collected directly from humans or treated with Toki extract to measure the inhibitory effect of collagenase activity. The specific experimental method is as follows.

実験に使用するトウキ抽出物は、商品名がトウキ抽出物(ANGELICA ACUTILOBA ROOT EXTRACT, Green Tech.の製品)であるトウキ抽出物を利用した。   As the Toki extract used in the experiment, a Toki extract whose trade name is Toki extract (product of ANGELICA ACUTILOBA ROOT EXTRACT, Green Tech.) Was used.

まず、ヒトの繊維芽細胞を培養用フラスコに入れ、約70〜80%程度成長するまで培養した後、トウキ抽出物で1日間処理し、細胞培養液を採取して、市販のコラゲナーゼ測定器具を用いてコラーゲンの生成度を測定した(Anal Biochem 116(1):172-7, 1987“An assay of collagenase activity using enzyme-linked immunosorbent assay for mammalian collagenase”参照)。すなわち、抗コラゲナーゼに対する抗体を用いてヒト由来MMP−1(Matrix Metalloproteinase-1)を定量することにより、コラゲナーゼの活性度を測定した。この際、トウキ抽出物で処理しない群を対照群として使用した。実験結果を下記表2に示す。

Figure 0005377815
First, human fibroblasts are placed in a culture flask and cultured until it grows to about 70 to 80%, then treated with a Japanese extract of cinnamon for 1 day, a cell culture solution is collected, and a commercially available collagenase measuring instrument is used. The production of collagen was measured (see Anal Biochem 116 (1): 172-7, 1987 “An assay of collagenase activity using enzyme-linked immunosorbent assay for mammalian collagenase”). That is, collagenase activity was measured by quantifying human-derived MMP-1 (Matrix Metalloproteinase-1) using an antibody against anti-collagenase. At this time, a group not treated with Toki extract was used as a control group. The experimental results are shown in Table 2 below.
Figure 0005377815

[試験例3]酵母抽出物のエラスチン生成促進効果
ヒトから直接採取するか、商業的に購入したヒトの繊維芽細胞を酵母抽出物で処理して、エラスチン生成効果を測定した。実験方法は、次の通りである。
[Test Example 3] Elastin production promoting effect of yeast extract The elastin production effect was measured by collecting human fibroblasts directly from humans or treating human fibroblasts with yeast extract. The experimental method is as follows.

実験に使用する酵母抽出物は、商品名がイーストエキストラクトまたはトニスキン(YEAST EXTRACTまたはTONISKIN, Silab Co.の製品)である酵母抽出物を利用した。   As the yeast extract used in the experiment, a yeast extract having a trade name of Yeast Extract or Toniskin (product of YEAST EXTRACT or TONISKIN, Silab Co.) was used.

まず、ヒトの繊維芽細胞を培養用フラスコに入れ、約70〜80%程度成長するまで培養した後、酵母抽出物を1日間処理し、細胞培養液を採取して、市販のエラスチン測定器具を用いてエラスチンの生成度を測定した。この際、酵母抽出物で処理しない群を対照群として使用した。実験結果を下記表3に示す。

Figure 0005377815
First, human fibroblasts are put in a culture flask and cultured until it grows to about 70 to 80%, then the yeast extract is treated for 1 day, a cell culture solution is collected, and a commercially available elastin measuring instrument is used. The elastin production rate was measured using this. At this time, a group not treated with the yeast extract was used as a control group. The experimental results are shown in Table 3 below.
Figure 0005377815

<実施例1及び比較例1〜7>
下記表4の組成に基づいて、化粧水の形態で実施例1及び比較例1〜7の化粧料組成物を製造した。

Figure 0005377815
<Example 1 and Comparative Examples 1-7>
Based on the composition of Table 4 below, cosmetic compositions of Example 1 and Comparative Examples 1 to 7 were produced in the form of a lotion.
Figure 0005377815

製造方法
(1)成分1〜3(A)及び成分4〜8(B)を各々75℃まで加熱する。
Production Method (1) Components 1 to 3 (A) and Components 4 to 8 (B) are each heated to 75 ° C.

(2)前記Bに前記Aを少しずつ添加しながら、7000rpmの速度で乳化攪拌する。次に、前記Aを全量添加した後、2分間乳化攪拌する。   (2) While adding the A to the B little by little, emulsify and stir at a speed of 7000 rpm. Next, after all the A is added, the mixture is emulsified and stirred for 2 minutes.

(3)次に、1分間2500rpmで攪拌して、組成物から空気を脱気する。   (3) Next, it stirs at 2500 rpm for 1 minute, and deaerates air from a composition.

(4)組成物が入れられたビーカーを氷水に浸漬し、28〜30℃まで冷却する。   (4) The beaker containing the composition is immersed in ice water and cooled to 28-30 ° C.

(5)得られた組成物を常温に24時間放置して安定化する。   (5) The obtained composition is allowed to stand at room temperature for 24 hours to be stabilized.

[試験例4]
ヘアレスマウス(Hairless mouse)に紫外線を8週間毎日1回(UVB 70mJ/cm)照射した後、2つの群(各群当たり20匹)に分けて、比較例1〜7及び実施例1を各々1ヶ月間毎日100ml/匹ずつ背部に塗布した後、皮膚を採取して、エラスチン及びコラーゲンの形成を組織学的に測定した。測定は、エラスチン及びコラーゲンをそれぞれ染色した後、その染色度を画像分析することにより、エラスチン及びコラーゲンの増加率を決定した。その実験結果を下記表5に示す。

Figure 0005377815
[Test Example 4]
After irradiating hairless mice with ultraviolet rays once a day for 8 weeks (UVB 70 mJ / cm 2 ), it was divided into two groups (20 mice per group), and Comparative Examples 1 to 7 and Example 1 were After applying 100 ml / animal on the back daily for one month, the skin was collected and the formation of elastin and collagen was measured histologically. In the measurement, after elastin and collagen were stained, the degree of increase in elastin and collagen was determined by image analysis of the degree of staining. The experimental results are shown in Table 5 below.
Figure 0005377815

前記表5の結果から明らかなように、銀杏葉抽出物だけを有効成分として含有する比較例2と、銀杏葉抽出物、トウキ抽出物及び酵母抽出物を有効成分として含有する実施例1とを比較すれば、実施例1がトウキ抽出物及び酵母抽出物によりエラスチンの顕著な増加率を示すことが分かる。   As is clear from the results of Table 5, Comparative Example 2 containing only Ginkgo biloba extract as an active ingredient and Example 1 containing Ginkgo biloba extract, Toki extract and yeast extract as active ingredients. By comparison, it can be seen that Example 1 shows a significant increase in elastin by the Toki extract and the yeast extract.

また、トウキ抽出物だけを有効成分として含有する比較例3と、トウキ抽出物、銀杏葉抽出物及び酵母抽出物を有効成分として含有する実施例1とを比較すれば、実施例1が銀杏葉抽出物及び酵母抽出物によりコラーゲンの顕著な増加率を示すことが分かる。   In addition, if Comparative Example 3 containing only a Toki extract as an active ingredient is compared with Example 1 containing a Toki extract, a Ginkgo biloba extract and a yeast extract as an active ingredient, Example 1 would be Ginkgo biloba. It can be seen that the extract and yeast extract show a significant increase in collagen.

[試験例5]保湿力及び皮膚弾力改善度(臨床試験)
上記で製造した実施例1及び比較例1〜7の化粧水に対して皮膚弾力回復効果を比較するために、30〜40代の女性280名を対象にし、20名を1つのグループとして14個のグループに分けて測定した。実験方法は、次の通りである。
[Test Example 5] Moisturizing power and skin elasticity improvement degree (clinical test)
In order to compare the skin elasticity recovery effect with the lotions of Example 1 and Comparative Examples 1 to 7 produced above, 280 women in their 30s and 40s were targeted, and 20 people as a group Measurements were divided into groups. The experimental method is as follows.

各グループに実施例1及び比較例1〜7を提供し、毎日1回1ヶ月間塗布するようにした。1ヶ月後、皮膚弾力を測定できるキュトメータ(cutometer;SEM474, Courage+Khazaka electronic GmbH. Germany)を用いて顔面部位の弾力を測定し、塗布前と比較した。また、コルネオメータ(corneometer; CM820 Courage+Khazaka electronic GmbH. Germany)を用いて保湿力を測定した。   Example 1 and Comparative Examples 1-7 were provided to each group and applied once a day for one month. One month later, the elasticity of the facial region was measured using a cutometer (SEM474, Courage + Khazaka electronic GmbH. Germany) capable of measuring skin elasticity, and compared with before application. Moreover, the moisture retention power was measured using a corneometer (CM820 Courage + Khazaka electronic GmbH. Germany).

実験結果は、各グループの平均値として下記表6に示した。

Figure 0005377815
The experimental results are shown in Table 6 below as average values for each group.
Figure 0005377815

前記表6の結果から明らかなように、銀杏葉抽出物だけを有効成分として含有する場合(比較例2)、又はトウキ抽出物だけを有効成分として含有する場合(比較例3)に比べて、これらの成分に加えて、酵母抽出物を有効成分としてさらに含有する場合(実施例1)のほうが、保湿力及び皮膚弾力改善度の双方において顕著な相乗效果を示すことが分かる。   As is clear from the results of Table 6 above, compared to the case where only the ginkgo biloba extract is contained as an active ingredient (Comparative Example 2) or the case where only the Toki extract is contained as an active ingredient (Comparative Example 3), In addition to these components, it can be seen that the case of further containing yeast extract as an active ingredient (Example 1) shows a remarkable synergistic effect in both moisturizing power and improvement in skin elasticity.

以上より、銀杏葉抽出物(Ginkgo extract)、トウキ抽出物(Angelic a acutiloba root extract)及び酵母抽出物(Yeast extract)の混合物は、皮膚弾力増進剤として有用であり、これらを含む組成物は、皮膚弾力増進用化粧料組成物として有用であることがわかる。   As mentioned above, the mixture of Ginkgo leaf extract (Ginkgo extract), Toki extract (Angelic a acutiloba root extract) and yeast extract (Yeast extract) is useful as a skin elasticity enhancer, and the composition containing these is It turns out that it is useful as a cosmetic composition for enhancing skin elasticity.

<実施例2>懸濁乳液化粧水
下記表7の組成に基づいて実施例2の懸濁乳液化粧水を製造した。

Figure 0005377815
<Example 2> Suspension emulsion lotion A suspension emulsion lotion of Example 2 was produced based on the composition shown in Table 7 below.
Figure 0005377815

<実施例3>エッセンス
下記表8の組成に基づいて実施例3のエッセンスを製造した。

Figure 0005377815
<Example 3> Essence The essence of Example 3 was produced based on the composition shown in Table 8 below.
Figure 0005377815

<実施例4>栄養クリーム
下記表9の組成に基づいて実施例4の栄養クリームを製造した。

Figure 0005377815
<Example 4> Nutritional cream The nutritional cream of Example 4 was manufactured based on the composition of Table 9 below.
Figure 0005377815

<実施例5>ジェル
下記表10の組成に基づいて実施例5のジェルを製造した。

Figure 0005377815
Example 5 Gel A gel of Example 5 was produced based on the composition shown in Table 10 below.
Figure 0005377815

<実施例6>パック
下記表11の組成に基づいて実施例6のパックを製造した。

Figure 0005377815
<Example 6> Pack A pack of Example 6 was manufactured based on the composition shown in Table 11 below.
Figure 0005377815

Claims (2)

有効成分として銀杏葉抽出物、トウキ抽出物、及び酵母抽出物を含有することを特徴とする皮膚弾力増進用化粧料組成物。   A cosmetic composition for enhancing skin elasticity, comprising a ginkgo biloba extract, a toki extract, and a yeast extract as active ingredients. 前記有効成分を組成物の総重量に対して各々0.01〜10.0重量%の量で含有することを特徴とする請求項1に記載の皮膚弾力増進用化粧料組成物。   The cosmetic composition for enhancing skin elasticity according to claim 1, wherein the active ingredient is contained in an amount of 0.01 to 10.0% by weight based on the total weight of the composition.
JP2005143034A 2004-05-17 2005-05-16 Cosmetic composition for enhancing skin elasticity Active JP5377815B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2004-0034837 2004-05-17
KR1020040034837A KR20050109815A (en) 2004-05-17 2004-05-17 Cosmetic composition for improving the skin elasticity

Publications (2)

Publication Number Publication Date
JP2005330281A JP2005330281A (en) 2005-12-02
JP5377815B2 true JP5377815B2 (en) 2013-12-25

Family

ID=35485176

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005143034A Active JP5377815B2 (en) 2004-05-17 2005-05-16 Cosmetic composition for enhancing skin elasticity

Country Status (2)

Country Link
JP (1) JP5377815B2 (en)
KR (1) KR20050109815A (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090122306A1 (en) 2005-11-15 2009-05-14 Omron Corporation Solder Material Inspecting Device
JP2011225550A (en) * 2010-03-30 2011-11-10 Cci Corp Matrix metalloprotease production suppressing and elastase activity inhibiting agent
KR102168532B1 (en) * 2014-07-01 2020-10-22 주식회사 엘지생활건강 Cosmetic composition for enhancing skin elasticity or improving skin wrinkle containing herb extracts
CN105997655A (en) * 2016-06-21 2016-10-12 安徽诚亚生物科技有限公司 Whitening cream and preparation method thereof
WO2018049608A1 (en) * 2016-09-14 2018-03-22 冯宝欣 Quantum light wave erugation and skincare cream and preparation method therefor
JP2018131405A (en) * 2017-02-15 2018-08-23 株式会社ファンケル Kallikrein 7 production-promoting composition
JP6285598B1 (en) * 2017-06-16 2018-02-28 株式会社ノエビア Collagen production promoter, heat shock protein production promoter, decorin production promoter
JP6351814B1 (en) * 2017-09-06 2018-07-04 株式会社ノエビア Topical skin preparation
CN112218616A (en) * 2018-03-23 2021-01-12 玫琳凯有限公司 Topical compositions and methods

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0623088B2 (en) * 1985-01-17 1994-03-30 株式会社コーセー Cosmetics
JPH04321615A (en) * 1991-04-19 1992-11-11 Kose Corp Skin medicine for external use
JP2000178168A (en) * 1998-12-18 2000-06-27 Ichimaru Pharcos Co Ltd Elastase activity inhibitor and cosmetic composition
JP2002326922A (en) * 2001-03-01 2002-11-15 Kose Corp Skin external preparation
JP2004010526A (en) * 2002-06-06 2004-01-15 Kose Corp Skin care preparation for external use

Also Published As

Publication number Publication date
JP2005330281A (en) 2005-12-02
KR20050109815A (en) 2005-11-22

Similar Documents

Publication Publication Date Title
JP5377815B2 (en) Cosmetic composition for enhancing skin elasticity
JP5312795B2 (en) Composition for improving skin condition and appearance and method of use thereof
RU2394555C2 (en) Cosmetic composition with anti-aging activity, which contains extract of aframomum angustifolium or longoza plants
CA2799223C (en) Compositions and methods for stimulating magp-1 to improve the appearance of skin
KR20060087817A (en) Anti-aging cosmetic composition
TW200528133A (en) Compositions of marine botanicals to provide nutrition to aging and environmentally damaged skin
KR20100135871A (en) Active ingredient that stimulates the proliferation and/or activity of fibroblasts
US11247077B2 (en) Synergistic extract of Palmaria palmata and jasmine, compositions comprising same and uses thereof
TW201206494A (en) Use of Tiliacora triandra in cosmetics and compositions thereof
JP2010514774A (en) Composition for improving skin condition and appearance and method of use thereof
JP2010504299A (en) Cosmetic use of active agents that stimulate matriptase expression
US6193975B1 (en) Use of potentilla erecta extract in the cosmetic and pharmaceutical field
WO2022069844A1 (en) Novel use of a peptide to improve the comfort of skin and/or mucous membranes and/or the appearance of dander
EP1269988B1 (en) Cosmetic or dermatological composition comprising acylaminoamide derivatives
US9084744B1 (en) Use of Tiliacora triandra in cosmetics and compositions thereof
KR20050103903A (en) Topical composition and methods for treatment of aged or environmentally damaged skin
EP2763652B1 (en) Use of glucans obtained from prunus persica as an anti-aging cosmetic agent
JP2005330285A (en) Skin moisturizing cosmetic composition
KR20050110720A (en) Cosmetic composition for moisturizing effect on the skin
CN113081942A (en) Multi-dimensional hydration cream containing apple stem cells
US8933036B2 (en) Cosmetic and/or pharmaceutical composition comprising a yeast peptide hydrolysate and use of the yeast peptide hydrolysate as an active agent for strengthening hair
JPH11100320A (en) Preparation for external use for skin
KR100558751B1 (en) Cosmetic composition for skin miosture
JPH11158054A (en) Skin lotion
KR102206595B1 (en) Fermented composition of ice plant and collagen for anti-aging and anti-wrinkle, method for preparing the same and cosmetic composition comprising the same

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080508

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20110308

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110329

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110719

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130925

R150 Certificate of patent or registration of utility model

Ref document number: 5377815

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250